GlassScriptPhysician profile
William A Godfrey
NPI 1154416345
$714.42
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.09 · 2022: $30.66 · 2023: $49.59 · 2024: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $199.48 | 2023-2024 | Real Intelligence, Journey II, Redapt |
| Abbott Laboratories | $187.37 | 2024 | Proclaim |
| Osteoremedies, LLC | $152.70 | 2024 | Osteoboost Select 10cc, Biowash Surgical Irrigation, Remedy Spectrum Gv Spacer |
| Stryker Corporation | $63.09 | 2021 | |
| Becton, Dickinson and Company | $45.44 | 2024 | Arista Ah Flexitip |
| Coloplast Corp | $30.66 | 2022 | |
| Ethicon US, LLC | $18.73 | 2024 | Dermabond Prineo |
| Solventum Corporation | $16.95 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Godfrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.